In contrast, calcimimetics such as cinacalcet and etelcalcetide are typically used to treat PTH-dependent hypercalcemia (e.g., primary and tertiary hyperparathyroidism) or to reduce PTH in secondary hyperparathyroidism [3, 4]. This evidence concerns the gene PTH and Hypercalcemia.